 COPENHAGEN, Denmark, April 21, 2021 GLOBE NEWSWIRE -- Ascendis Pharma AS Nasdaq: ASND, a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced presentations featuring TransCon hGH lonapegsomatropin at two upcoming medical conferences: Pediatric Endocrinology Nursing Society PENS national conference, taking place virtually April 21-23, and the Pediatric Endocrine Society PES annual meeting, taking place virtually April 30 May 3, 2021. 